Last updated on October 2018

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

Brief description of study

This study will evaluate the long-term safety and tolerability of rapastinel as an adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD).

Clinical Study Identifier: NCT03002077

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Registry Team

Adams Clinical Trials
Watertown, MA United States

Clinical Trials Registry Team

Boston Clinical Trials
Boston, MA United States